PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DRUG vs. QQQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between DRUG and QQQ is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

DRUG vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bright Minds Biosciences Inc (DRUG) and Invesco QQQ (QQQ). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%SeptemberOctoberNovemberDecember2025February
54.81%
72.95%
DRUG
QQQ

Key characteristics

Sharpe Ratio

DRUG:

1.42

QQQ:

1.44

Sortino Ratio

DRUG:

24.65

QQQ:

1.95

Omega Ratio

DRUG:

3.92

QQQ:

1.26

Calmar Ratio

DRUG:

21.15

QQQ:

1.94

Martin Ratio

DRUG:

56.58

QQQ:

6.71

Ulcer Index

DRUG:

36.51%

QQQ:

3.92%

Daily Std Dev

DRUG:

1,461.70%

QQQ:

18.27%

Max Drawdown

DRUG:

-97.67%

QQQ:

-82.98%

Current Drawdown

DRUG:

-25.05%

QQQ:

0.00%

Returns By Period

In the year-to-date period, DRUG achieves a 16.05% return, which is significantly higher than QQQ's 5.27% return.


DRUG

YTD

16.05%

1M

16.37%

6M

3,806.54%

1Y

2,032.76%

5Y*

N/A

10Y*

N/A

QQQ

YTD

5.27%

1M

4.15%

6M

13.63%

1Y

24.59%

5Y*

18.87%

10Y*

18.50%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DRUG vs. QQQ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DRUG
The Risk-Adjusted Performance Rank of DRUG is 9797
Overall Rank
The Sharpe Ratio Rank of DRUG is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of DRUG is 100100
Sortino Ratio Rank
The Omega Ratio Rank of DRUG is 100100
Omega Ratio Rank
The Calmar Ratio Rank of DRUG is 100100
Calmar Ratio Rank
The Martin Ratio Rank of DRUG is 100100
Martin Ratio Rank

QQQ
The Risk-Adjusted Performance Rank of QQQ is 5858
Overall Rank
The Sharpe Ratio Rank of QQQ is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of QQQ is 5454
Sortino Ratio Rank
The Omega Ratio Rank of QQQ is 5757
Omega Ratio Rank
The Calmar Ratio Rank of QQQ is 6161
Calmar Ratio Rank
The Martin Ratio Rank of QQQ is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DRUG vs. QQQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bright Minds Biosciences Inc (DRUG) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DRUG, currently valued at 1.42, compared to the broader market-2.000.002.004.001.421.44
The chart of Sortino ratio for DRUG, currently valued at 24.65, compared to the broader market-6.00-4.00-2.000.002.004.006.0024.651.95
The chart of Omega ratio for DRUG, currently valued at 3.92, compared to the broader market0.501.001.502.003.921.26
The chart of Calmar ratio for DRUG, currently valued at 21.15, compared to the broader market0.002.004.006.0021.151.94
The chart of Martin ratio for DRUG, currently valued at 56.58, compared to the broader market-10.000.0010.0020.0030.0056.586.71
DRUG
QQQ

The current DRUG Sharpe Ratio is 1.42, which is comparable to the QQQ Sharpe Ratio of 1.44. The chart below compares the historical Sharpe Ratios of DRUG and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
1.42
1.44
DRUG
QQQ

Dividends

DRUG vs. QQQ - Dividend Comparison

DRUG has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.53%.


TTM20242023202220212020201920182017201620152014
DRUG
Bright Minds Biosciences Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QQQ
Invesco QQQ
0.53%0.56%0.62%0.80%0.43%0.55%0.74%0.91%0.84%1.06%0.99%1.41%

Drawdowns

DRUG vs. QQQ - Drawdown Comparison

The maximum DRUG drawdown since its inception was -97.67%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for DRUG and QQQ. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-25.05%
0
DRUG
QQQ

Volatility

DRUG vs. QQQ - Volatility Comparison

Bright Minds Biosciences Inc (DRUG) has a higher volatility of 22.51% compared to Invesco QQQ (QQQ) at 5.01%. This indicates that DRUG's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%SeptemberOctoberNovemberDecember2025February
22.51%
5.01%
DRUG
QQQ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab